A new mouse model may be critical for understanding the most aggressive types of pancreatic cancer and finding ways to prevent its growth and recurrence.
A new book by a Columbia gastroenterologist focuses on inflammation, disease, and diet and explains how Inflammation is not only a consequence of disease, but also a potential root cause of it.
A study of mice found that dietary sugar alters the gut microbiome, setting off a chain of events that leads to metabolic disease, pre-diabetes, and weight gain.
More than a dozen experimental drugs designed to help people with celiac disease are now in clinical trials, raising hope that gluten could one day be back on the menu for many.
People with gluten sensitivity have an antibody profile that differs from that of people with celiac disease, which could help doctors diagnose gluten sensitivity.
Bo Shen, MD, and Neal LeLeiko, MD, PhD, leaders in caring for adults and children with inflammatory bowel disease (IBD), are taking on key roles at VP&S and NewYork-Presbyterian/CUIMC.
A new study suggests that depression and GI trouble sometimes spring from the same source—low serotonin—and identifies a potential treatment that could ease both conditions.